Taken together, current evidence indicates that while a definitive causal relationship between GLP-1 RA therapy and severe motility disorders has not been established, clinicians should remain vigilant for GI symptoms suggestive of delayed gastric emptying or obstruction
Hypertension 81 , e41e43 (2024)
Not a fit for compounded GLP-1? You may still qualify for our Microdosing program, a lower dose option designed for patients outside the standard BMI range
DOI: 10.1007/s00210-025-04675-x [Google Scholar] da Silva Lima N, Cabaleiro A, Novoa E, Riobello C, Knerr PJ, He Y, et al
When it comes to losing weight, diet and exercise alone dont work for everyone, especially people with chronic conditions like diabetes